Medicine & Life Sciences
Pioglitazone
80%
Overweight
56%
Obesity
26%
Phospholipids
22%
HDL3 Lipoprotein
20%
HDL2 Lipoprotein
19%
Cardiovascular Diseases
18%
Placebos
17%
Aryldialkylphosphatase
16%
Immunodiffusion
15%
Apolipoproteins
15%
Apolipoprotein A-I
14%
Enzyme Assays
14%
LDL Lipoproteins
13%
Lipoproteins
12%
HDL Cholesterol
11%
Epidemics
10%
Cholesterol
9%
Public Health
9%
Incidence
6%
Therapeutics
2%
Chemistry
Pioglitazone
100%
Apolipoprotein
31%
Oxidation Reaction
28%
Phospholipid
21%
Anti Atherogenis
20%
High-Density Lipoprotein
16%
Low-Density Lipoprotein
14%
Lipoprotein
14%
Oxidation Potential
13%
Cholesterol
11%
Resistance
8%